Santhera Pharmaceuticals Holding AG (SANN) — Free Cash Flow Generation Index

Latest as of December 2023: 1.00x

Santhera Pharmaceuticals Holding AG (SANN) has a Free Cash Flow Generation Index of 1.00x as of December 2023. Free cash flow of CHF62.54 Million represents 1% of operating cash flow (CHF62.63 Million). Explore Santhera Pharmaceuticals Holding AG capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

1.00x

Free Cash Flow / Operating CF

Free Cash Flow

CHF62.54 Million

CHF

Operating Cash Flow

CHF62.63 Million

CHF

Capital Expenditures

CHF90.00K

CHF

Santhera Pharmaceuticals Holding AG Free Cash Flow Generation Index (2019–2023)

Historical FCF Generation Index trend for Santhera Pharmaceuticals Holding AG across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Santhera Pharmaceuticals Holding AG.

Annual Free Cash Flow Generation for Santhera Pharmaceuticals Holding AG (2019–2023)

Year-by-year Free Cash Flow Generation Index for Santhera Pharmaceuticals Holding AG. Check Santhera Pharmaceuticals Holding AG (SANN) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (CHF)	Operating CF	Capital Expenditures	YoY Change
2023	0.50x	CHF23.53 Million	CHF47.27 Million	CHF23.74 Million	▼ -45.4%
2019	0.91x	CHF2.37 Million	CHF2.60 Million	CHF229.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).